tradingkey.logo

Bright Minds Biosciences Inc

DRUG
82.120USD
-2.540-3.00%
Close 12/26, 16:00ETQuotes delayed by 15 min
627.05MMarket Cap
LossP/E TTM
You can find the annual or quarterly income statement of Bright Minds Biosciences Inc here for insights into the performance and operational efficiency of Bright Minds Biosciences Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Operating expenses
----
1482.95%2.38M
485.29%2.39M
-9.58%1.14M
-54.00%549.50K
-116.04%-172.07K
-73.13%408.75K
-26.29%1.26M
-46.22%1.19M
-48.55%1.07M
-56.36%1.52M
-54.86%1.71M
-4.25%2.22M
-27.98%2.08M
170.19%3.49M
655.40%3.79M
--2.32M
--2.89M
--1.29M
--501.72K
----
----
----
----
R&D expenses
1105.94%3.50M
619.91%1.95M
483.02%1.84M
-19.17%736.64K
-64.82%289.87K
-65.33%270.64K
-69.66%315.03K
-16.35%911.31K
-56.08%823.94K
-51.39%780.66K
-64.37%1.04M
-63.94%1.09M
8.64%1.88M
-25.27%1.61M
271.49%2.91M
1302.04%3.02M
--1.73M
--2.15M
--784.57K
--215.47K
----
----
----
----
Depreciation, depletion, and amortization
----
-13.17%11.47K
21.12%16.13K
12.66%15.17K
-3.10%13.25K
-1.86%13.21K
-1.01%13.32K
-0.37%13.47K
206.83%13.67K
--13.46K
--13.45K
--13.52K
--4.46K
----
----
----
----
----
----
----
----
----
----
----
Other operating expenses
----
----
----
----
----
---683.90K
---237.69K
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--0.00
--0.00
--1.21K
--13.61K
----
----
----
----
Operating profit
----
-1482.95%-2.38M
-485.29%-2.39M
9.58%-1.14M
54.00%-549.50K
116.04%172.07K
73.13%-408.75K
26.29%-1.26M
46.22%-1.19M
48.55%-1.07M
56.36%-1.52M
54.86%-1.71M
4.25%-2.22M
27.98%-2.08M
-170.19%-3.49M
-655.40%-3.79M
---2.32M
---2.89M
---1.29M
---501.72K
----
----
----
----
Net non-operating interest income (expenses)
Non-operating interest income
9144.97%386.92K
3054.17%344.70K
--365.02K
--3.04K
--4.19K
--10.93K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Non-operating interest expense
----
581.31%6.17K
522.55%9.73K
105.96%4.55K
-36.46%1.82K
-73.38%904.91
-60.53%1.56K
-51.12%2.21K
78.19%2.86K
--3.40K
--3.96K
--4.52K
--1.60K
----
----
----
----
----
----
----
----
----
----
----
Gains from sale of securities
11457.76%955.19K
-13321.61%-1.94M
-552.74%-77.17K
10642.72%1.18M
-81.11%8.26K
-92.53%-14.46K
-555.46%-11.82K
139.52%10.95K
13.57%43.74K
-324.45%-7.51K
132.66%2.60K
-3.49%-27.72K
-50.57%38.51K
-96.30%3.35K
64.45%-7.95K
-3.79%-26.78K
--77.91K
--90.52K
---22.36K
---25.80K
----
----
----
----
Special income (expenses)
----
----
----
----
--0.00
----
----
----
100.00%0.00
----
----
----
---1.48K
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
----
--186.65K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income before tax
----
-2363.68%-3.79M
-400.84%-2.11M
102.79%34.96K
53.29%-538.87K
115.47%167.64K
72.28%-422.13K
28.15%-1.25M
47.22%-1.15M
47.94%-1.08M
56.42%-1.52M
54.33%-1.74M
2.50%-2.19M
25.78%-2.08M
-166.20%-3.49M
-623.53%-3.82M
---2.24M
---2.80M
---1.31M
---527.53K
----
----
----
----
Income after tax
----
-2363.68%-3.79M
-400.84%-2.11M
102.79%34.96K
53.29%-538.87K
115.47%167.64K
72.28%-422.13K
28.15%-1.25M
47.22%-1.15M
47.94%-1.08M
56.42%-1.52M
54.33%-1.74M
2.50%-2.19M
25.78%-2.08M
-166.20%-3.49M
-623.53%-3.82M
---2.24M
---2.80M
---1.31M
---527.53K
----
----
----
----
Net income from continuous operations
-453.98%-2.99M
-2363.68%-3.79M
-400.84%-2.11M
102.79%34.96K
53.29%-538.87K
115.47%167.64K
72.28%-422.13K
28.15%-1.25M
47.22%-1.15M
47.94%-1.08M
56.42%-1.52M
54.33%-1.74M
2.50%-2.19M
25.78%-2.08M
-166.20%-3.49M
-623.53%-3.82M
-689.08%-2.24M
-6971.50%-2.80M
-29945.69%-1.31M
-1531.26%-527.53K
---284.12K
---39.65K
---4.37K
---32.34K
Net income attributable to controlling interests
-453.98%-2.99M
-2363.68%-3.79M
-400.84%-2.11M
102.79%34.96K
53.29%-538.87K
115.47%167.64K
72.28%-422.13K
28.15%-1.25M
47.22%-1.15M
47.94%-1.08M
56.42%-1.52M
54.33%-1.74M
2.50%-2.19M
25.78%-2.08M
-166.20%-3.49M
-623.53%-3.82M
-689.08%-2.24M
-6971.50%-2.80M
-29945.69%-1.31M
-1531.26%-527.53K
---284.12K
---39.65K
---4.37K
---32.34K
Net income attributable to common shareholders
-453.98%-2.99M
-2363.68%-3.79M
-400.84%-2.11M
102.79%34.96K
53.29%-538.87K
115.47%167.64K
72.28%-422.13K
28.15%-1.25M
47.22%-1.15M
47.94%-1.08M
56.42%-1.52M
54.33%-1.74M
2.50%-2.19M
25.78%-2.08M
-166.20%-3.49M
-623.53%-3.82M
-689.08%-2.24M
-6971.50%-2.80M
-29945.69%-1.31M
-1531.26%-527.53K
---284.12K
---39.65K
---4.37K
---32.34K
Basic earnings per share
-242.71%-0.41
-1526.52%-0.54
-217.64%-0.30
101.74%0.01
60.62%-0.12
102.61%0.04
76.48%-0.09
32.93%-0.33
61.23%-0.31
-63.72%-1.44
72.73%-0.40
69.85%-0.49
16.49%-0.79
29.16%-0.88
-55.68%-1.47
-253.69%-1.61
-325.69%-0.94
-3896.93%-1.24
-27645.21%-0.95
-1704.08%-0.46
---0.22
---0.03
--0.00
---0.03
Diluted earnings per share
-242.71%-0.41
-1585.65%-0.54
-217.64%-0.30
101.74%0.01
60.62%-0.12
102.51%0.04
76.48%-0.09
32.93%-0.33
61.23%-0.31
-63.72%-1.44
72.73%-0.40
69.85%-0.49
16.49%-0.79
29.16%-0.88
-55.68%-1.47
-253.69%-1.61
-325.69%-0.94
-3896.93%-1.24
-27645.21%-0.95
-1704.08%-0.46
---0.22
---0.03
--0.00
---0.03
Dividend per share
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
----
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

FAQs

What is the income statement?

The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.
KeyAI